BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
IVDs on the rise
Radiopharmaceuticals
Science '22 in Review
Top Biopharma Trends of 2022
Top Med-tech Trends of 2022
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, October 4, 2023
See today's BioWorld
Home
» Other news to note for May 4, 2020
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full article
sign up for free
or
sign in
.
Other news to note for May 4, 2020
May 4, 2020
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adare, Alnylam, Applied Biomath, Applied DNA Sciences, Anixa, Biomarin, Brainstorm, Celltrion, Corium, Destiny, Dinaqor, Domain, Eagle, Galecto, Lilly, Generex, Genfa, Harbour Biomed, Ipsen, Junshi, Kempharm, Lilly, Mediwound, Merck, Nanoviricides, Neuralis, Noachis Terra, Ontochem, Oragenics, Orbis, Recce, Specialty Therapeutics, Surrozen, Teva, Transgene, Vaxxel, VBL, Vir, Zymeworks.
BioWorld
Briefs
Other news to note
Coronavirus